Why Do Treatments Have Different Side Effects: Let's Find Out!

Read the full conversation on Oncology Data Advisor: https://oncdata.com/sabcs-2025-chase-hundal At the 2025 San Antonio Breast Cancer Symposium (SABCS), Editorial Board member Jasmin Hundal, MD, MS, MPH, and breast cancer survivor and advocate Megan‑Claire “Warrior Megsie” Chase reflect on how research, clinical care, and lived experience come together to shape the future of breast cancer care. They discuss what it means to attend SABCS as a 10‑year invasive lobular breast cancer survivor, the emotional reality of fear of recurrence, and the power of seeing patient advocates leading posters, panels, and conversations. Ms. Chase shares her journey from communications and theater into research collaboration and co‑authorship, including her poster on real‑world patient and caregiver experiences with fear of recurrence, while Dr. Hundal highlights why language around “non‑adherence” often obscures the true burden of long‑term endocrine side effects and why quality of life must be treated as a primary outcome. The conversation also explores digital health and wearables in breast cancer survivorship, balancing the promise of earlier detection of issues through technology with concerns about equity, inclusion of older adults, and preserving human connection. Together, they underscore that patient experience is a form of expertise—and that survivors’ voices are essential to driving meaningful, patient‑centered research. #SABCS2025 #BreastCancer #BreastCancerSurvivor #LobularBreastCancer #PatientAdvocacy #FearOfRecurrence #EndocrineTherapy #QualityOfLife #DigitalHealth #Wearables #OncologyFellow #CancerSurvivorship #OncologyDataAdvisor